Clinics and pharmacies nationwide as a prescribed medicine from July 2018 through August 2019. The container was included in the price of the medication, which varied based on quantities prescribed, health insurance terms and other factors. recalls
1 recall recorded since 2018, most recently on 29 August 2019. Status and classification are as published by the CPSC.
Recalls1
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 29 August 2019
- Reason
- The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
- Remedy
- Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
- Recall number
- 19194
- Losartan Potassium and Ezetimibe prescription drug bottles
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.